[Retracted] Fangchinoline targets PI3K and suppresses PI3K/AKT signaling pathway in SGC7901 cells

【已撤稿】方奇诺林靶向PI3K并抑制SGC7901细胞中的PI3K/AKT信号通路

阅读:1

Abstract

Following the publication of the above article, a concerned reader has drawn to the Editor's attention that there were a number of apparently overlapping data panels shown in Fig. 4C and D on p. 2360 such that the data would have drawn from a smaller number of original sources, where the data panels were intended to show the results from differently performed experiments. Moreover, certain of the data shown in Figs. 2D, 3B, C and E and 4F contained data that were strikingly similar to data that have appeared in other publications written by different authors at different research institutes.  In view of the substantial number of overlapping data panels identified in Fig. 4C and D, and the fact that certain of the data in the above article have appeared in other published articles, the Editor of International Journal of Oncology has decided that this paper should be retracted from the publication on account of a lack of confidence in the presented data. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [International Journal of Oncology 46: 2355‑2363, 2015; DOI: 10.3892/ijo.2015.2959].

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。